Pingkuan Zhang Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

10/2017

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pingkuan Zhang Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 07/2016
6	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2019
4	Neoplasms (Cancer) 12/2023 - 08/2013
4	Disease Progression 06/2022 - 07/2016
3	Hypertension (High Blood Pressure) 12/2022 - 10/2017
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 09/2019
2	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2022
2	Diarrhea 12/2022 - 12/2022
2	Brain Neoplasms (Brain Tumor) 12/2021 - 07/2016
2	Vomiting 01/2021 - 10/2017
2	Melanoma (Melanoma, Malignant) 11/2017 - 07/2016
1	Body Weight (Weight, Body) 01/2023
1	Nausea 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Fatigue 01/2021
1	Constipation 01/2021
1	Exanthema (Rash) 12/2020
1	Neutropenia 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Ovarian Epithelial Carcinoma 01/2018
1	Fever (Fevers) 10/2017
1	Esophageal Squamous Cell Carcinoma 08/2013

Drug/Important Bio-Agent (IBA)

19	brigatinibIBA 01/2024 - 09/2019
11	Anaplastic Lymphoma KinaseIBA 01/2024 - 09/2019
8	Tyrosine Kinase InhibitorsIBA 05/2023 - 05/2021
8	CrizotinibIBA 01/2023 - 09/2019
4	alectinibIBA 12/2022 - 05/2021
3	mobocertinibIBA 12/2023 - 01/2023
3	PlatinumIBA 12/2023 - 01/2023
3	dabrafenibIBA 11/2017 - 07/2016
3	trametinibIBA 11/2017 - 07/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 12/2022 - 12/2022
2	ceritinibIBA 12/2022 - 05/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017 - 07/2016
1	amivantamab-vmjwIBA 12/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	BilirubinIBA 01/2023
1	A 7 (A-7)IBA 01/2023
1	Amylases FDA Link 12/2020
1	Phosphotransferases (Kinase)IBA 12/2020
1	NivolumabIBA 07/2018
1	Docetaxel (Taxotere)FDA Link 07/2018
1	pembrolizumabIBA 07/2018
1	pazopanib FDA Link 01/2018
1	TabletsIBA 11/2017
1	Alanine Transaminase (SGPT)IBA 10/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2017
1	Mitogen-Activated Protein KinasesIBA 07/2016
1	Fluorouracil (Carac)FDA LinkGeneric 08/2013
1	Lapatinib (GW572016)FDA Link 08/2013

Therapy/Procedure

8	Therapeutics 12/2023 - 07/2016
2	Drug Therapy (Chemotherapy) 12/2023 - 01/2023